KRISTEN KEEN: Open Payments
NPI 1649985581 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 73 payments from 16 companies in 2025. Trend: 2023 $706 · 2024 $1,531 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 17 | $401 |
| AstraZeneca Pharmaceuticals LP | 11 | $325 |
| Janssen Biotech, Inc. | 10 | $178 |
| Merck Sharp & Dohme LLC | 8 | $134 |
| GlaxoSmithKline, LLC. | 6 | $117 |
| Caris MPI, Inc. | 3 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Incyte Corporation | 2 | $38 |
| Stemline Therapeutics Inc. | 2 | $36 |
Products named: Enhertu, DATROWAY, KEYTRUDA, LYNPARZA, TALVEY, MI CANCER SEEK, OJJAARA, DARZALEX.
Industry payments across NJ — which companies pay providers there.
